Chemistry: molecular biology and microbiology – Vector – per se
Reexamination Certificate
2006-05-23
2006-05-23
Priebe, Scott D. (Department: 1635)
Chemistry: molecular biology and microbiology
Vector, per se
C514S04400A, C424S093200
Reexamination Certificate
active
07049132
ABSTRACT:
This invention relates to compositions and methods for selective expression of a heterologous nucleic acid sequence in a targeted tissue, and more particularly to the glucose regulated protein 78 (grp78) stress-responsive promoter and its use in gene therapy and the production of transgenic animals.
REFERENCES:
patent: 5196523 (1993-03-01), Lee
patent: 5811231 (1998-09-01), Farr et al.
Anderson et al., Nature, vol. 392, pp. 25-30, Apr. 1998.
Verma, Nature, vol. 389, pp. 239-242, 1997.
Gomez-Navarro et al., European Journal of Cancer, vol. 35, pp. 868, 1999.
Vile et al., Gene Therapy, vol. 7, pp. 2-8, 2000.
Little et al., “The glucose-regulated proteins (GRP78 and GRP94): function, gene regulation, and applications,”Critical Reviews In Eukaryotic Gene Expression, 1994, vol. 4, No. 1, pp. 1-18.
Walther et al., “Targeted vectors for gene therapy of cancer and retroviral infections,”Molecular Biotechnology, 1996, vol. 6, pp. 267-286.
Roy et al., “Transduction of Calcium Stress through Interaction of the Human Transcription Factor CBF with the Proximal CCAAT Regulatory Element of the grp 78/BiP Promoter,” Molecular and Cellular Biology, vol. 15, No. 4, p. 2263-2274 (1995).
Tillman et al., “Structure and regulation of the mouse GRP78 (BiP) promoter by glucose and calcium ionophore,” Gene, vol. 158, No. 2, p. 225-229 (1995).
Gazit et al., “Use of the Stress-Inducible grp78/BiP Promoter in Targeting High Level Gene Expression in Fibrosarcoma in Vivo,” Cancer Research, vol. 55, p. 1660-1663 (1995).
Little et al., “Generation of a Mammalian Cell Line Deficient in Glucose-regulated Protein Stress Induction through Targeted Ribozyme Driven by a Stress-inducible Promoter,” The Journal of Biological Chemistry, vol. 270, No. 16, p. 9526-9534 (1995).
Cao et al., “Requirement of Tyrosine- and Serine/Threonine Kinases in the Transcriptional Activation of the Mammalian grp78/Bi) Promoter by Thapsigargin,” The Journal of Biological Chemistry, vol. 270, No. 1, p. 494-502 (1995).
Gazit et al., “Use of the Glucose Starvation-inducible Glucose-regulated Protein 78 Promoter in Suicide Gene Therapy of Murine Fibrosarcoma,” Cancer Research, vol. 59, p. 3100-3106 (1999).
Li et al., “Transactivation of the grp78 Promoter by Ca2+Depletion,” The Journal of Biological Chemistry, vol. 268, No. 16, p. 12003-12009 (1993).
Mullen, “Metabolic Suicide Genes in Gene Therapy,” Pharmac. Ther., vol. 63, p. 199-207 (1994).
Kyu Seong Kim et al., “Expression of the Glucose-Regulated Proteins (GRP94 an GRP78) in Differentiated and Undifferentiated Mouse Embryonic Cells and the Use of the GRP78 promoter as an expression system in embryonic cells” Differentiation, Springer Verlag, DE, vol. 42, No. 3, Feb. 1990-02 pp. 153-159.
Roy B et al., “The Mammalian Endoplasmic Retriculum Stress Response Element Consists of an Evolutionarily conserved tripartite structure and interacts with a novel stress-inducible complex” Nucleic Acids Research, Oxford University Press, Surrey, Great Britain, vol. 27, No. 6, 1999, pp. 1437-1443.
Yoshida H et al., “Identification of the CIS-Acting Endoplasmic Reticulum Stress Response Element Responsible for Transcriptional Induction of Mammalian Glucose-Regulated Proteins” Journal of Biological Chemistry, American Society of Biological Chemists, Baltimore, MD, vol. 273, No. 50, 1998, pp. 33741-33749.
Fish & Richardson P.C.
Priebe Scott D.
University of Southern California
Whiteman Brian
LandOfFree
Stress-responsive induction of a therapeutic agent and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stress-responsive induction of a therapeutic agent and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stress-responsive induction of a therapeutic agent and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3639190